BioSpace News Archive

U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19

Asprihale® is intended for emergency treatment to reduce the risk of vascular mortality in patients with suspected acute myocardial infarction (MI).

Antisense Therapeutics Limited is pleased to advise of the appointment of Gil Price M.D. as Consultant Medical Director..

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at the Cowen Health Care Conference in Boston, MA on Tuesday, March 3rd, 2020 at 9:20 a.m. ET.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the fourth quarter and full year ended December 31, 2019.

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference on Wednesday March 4, 2020 at 11:20 am Eastern Time.

Akcea Therapeutics, Inc. (NASDAQ:AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases, today announced that Damien McDevitt, Interim CEO, will present at the Cowen 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 10:40 a.m. ET.

BLACKSBURG, Va., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced that Dr. Josep Bassaganya-Riera, Chairman, President and Chief Executive Officer, will present a company overview at the Cowen and Company 40 th Annual Health Care Conference. The presentation will take place on Monday, March 2, 2020, at 10:30 a.m. EST at the Boston Marrio

WALTHAM, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced that the company will present at the 40th Annual Cowen Health Care Conference on Wednesday, March 4, 2020 at 10:00 a.m. ET in Boston, Mass. The presentation will be given by Cedric Francois, M.D., Ph.D., co-founder and chief executive officer of Apellis, and will be available via live webcast from the “Events and

Interim results in the EVoluSIon Study on the SImmetry® System further show 78 percent of patients are opioid-free at 24 months